Abstract 9846: Dietary Supplement Use and AHA Dietary Guidance Alignment Among U.S. Adults Recommended for Lipid-Lowering Therapy
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.9846 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Sridhar Mangalesh und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Background
The 2026 AHA/ACC Dyslipidemia guideline gives a Class 3 recommendation against dietary supplements for LDL-C or triglyceride lowering. The 2026 AHA Dietary Guidance to Improve Cardiovascular Health emphasizes diet quality as a foundational prevention strategy. Nevertheless, supplement use is common. Studying these recommendations together may clarify whether supplement use occurs alongside broader evidence-based prevention measures or alongside untreated dyslipidemia and dietary misalignment. Research Question: We quantified ‘cholesterol or heart health’ supplement use and its alignment with adherence to the 2026 AHA dietary guidance among U.S. adults, stratified by 2026 AHA/ACC guideline-defined eligibility for lipid-lowering therapy (LLT).
Methods
We analyzed adults aged 30-75 years in the NHANES 2015-2020 fasting subsample. LLT use was assessed from prescription medication files. Untreated adults were classified as ‘recommended for LLT’, ‘reasonable/selectively consider LLT’, or ‘LLT not routinely recommended’, using 2026 dyslipidemia guideline criteria incorporating LDL-C, ASCVD, diabetes, CKD, and PREVENT risk. ‘Cholesterol or Heart Health’ supplement use in the past 30 days was identified from questionnaire data, including clinician or self-initiated use. Harmonized dietary-recall and Food Patterns Equivalents Database data were used to assess adequate intake of dietary components. These included guideline-aligned intakes of fruit, vegetables, whole grains, seafood, added sugars, sodium, saturated fat, fiber, and alcohol, based on the 2026 AHA dietary guidance (Figure 1).
Results
We analyzed 3,743 U.S. adults (weighted, 147.3 million). Overall, 25.0% (36.8 million) were on LLT (treated), and 22.6% (33.3 million) were untreated but recommended for LLT. Supplement use was reported by 11.3% (16.7 million), including 19.5% (7.2 million) of adults receiving LLT, and 12.8% (4.2 million) of untreated adults recommended for LLT (Figure 2). Among 4.2 million untreated supplement users recommended for LLT, 55.8% reported self-initiated, and 39.5% reported clinician-recommended use. Dietary inadequacies were common, ranging from 65.1% for excess saturated fat to 90.7% for inadequate whole grain intake. The weighted median dietary inadequacy count was 7 (IQR, 6-8). Supplement use was not significantly associated with alignment with the 2026 AHA dietary guidance (p=0.083).
Conclusion
In this nationally representative analysis, supplement use was common among LLT-treated adults and present among millions of untreated adults recommended for LLT, while dietary misalignment was widespread across LLT eligibility strata. These findings characterize a prevention gap in which supplement use should prompt clarification of LLT expectations and reinforce discussions about evidence-based pharmacotherapy and improvements in dietary patterns.
Zitieren
APA
Mangalesh, S., Kaushik, S., Karthikeyan, A., Tale, E., Vats, V., Waseem, Z., Afridi, Q. A. A., Alper, A., Kumar, S. S., & Ostfeld, R. (2026). Abstract 9846: Dietary Supplement Use and AHA Dietary Guidance Alignment Among U.S. Adults Recommended for Lipid-Lowering Therapy. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.9846
Vancouver
Mangalesh S, Kaushik S, Karthikeyan A, Tale E, Vats V, Waseem Z, et al. Abstract 9846: Dietary Supplement Use and AHA Dietary Guidance Alignment Among U.S. Adults Recommended for Lipid-Lowering Therapy. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.9846
BibTeX
@article{Mangalesh2026,
author = {Mangalesh, Sridhar and Kaushik, Sharanya and Karthikeyan, Aditya and Tale, Ermin and Vats, Vaibhav and Waseem, Zaha and Afridi, Qudsiya Asif Aleem and Alper, Adir and Kumar, Sriram Sunil and Ostfeld, Robert},
title = {Abstract 9846: Dietary Supplement Use and AHA Dietary Guidance Alignment Among U.S. Adults Recommended for Lipid-Lowering Therapy},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.9846}
}
EUVIMED